06.08.2019 LANXESS Aktiengesellschaft  DE0005470405

DGAP-Adhoc: LANXESS Aktiengesellschaft: LANXESS to sell 40% stake in chemical park operator Currenta


 

DGAP-Ad-hoc: LANXESS Aktiengesellschaft / Key word(s): Disposal
LANXESS Aktiengesellschaft: LANXESS to sell 40% stake in chemical park operator Currenta

06-Aug-2019 / 20:41 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


- Currenta valued at enterprise value of EUR 3.5 billion
(100% including real estate)

- Equity value of LANXESS' 40% stake approximately
EUR 780 million pre tax

- Buyer is the world's largest infrastructure investor Macquarie Infrastructure and Real Assets

- LANXESS' strategic interest will be secured by 10 year service- and supply contracts for the three production sites in Leverkusen, Krefeld-Uerdingen und Dormagen

Cologne - Specialty chemicals company LANXESS signed on August 6, 2019, an agreement to sell its 40% share in the chemical park operator Currenta to funds managed by Macquarie Infrastructure and Real Assets (MIRA). Currenta manages and operates the chemical parks in Leverkusen, Dormagen and Krefeld-Uerdingen.

The transaction is subject to the approval of the responsible regulatory authorities. Closing is expected until the end of April 2020. Currently, Currenta is a joint venture of Bayer (60%) and LANXESS (40%).

The 40% stake of Currenta held by LANXESS accounts for an equity value (after deduction of net debt and pensions) of approximately
EUR 780 million pre tax. In addition, LANXESS is entitled to a profit participation until completion of the transaction. Moreover, LANXESS has reached an agreement with MIRA on service and supply contracts for the three sites in Leverkusen, Dormagen and Krefeld-Uerdingen, which will initially run for 10 years.

With the long-term contract package, LANXESS has secured a reliable infrastructure at competitive conditions for the future. At the same time the sale of the 40% stake will give LANXESS additional financial leeway.


Cologne, August 6, 2019

Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.
 




Contact:
Katharina Forster

LANXESS AG
Investor Relations Manager

Kennedyplatz 1
50569 Köln, Deutschland
Telefon: +49 221 8885-1035
Fax: +49 221 8885-4944
Mobil: +49 151 74612789
E-Mail: [email protected]

06-Aug-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: LANXESS Aktiengesellschaft
Kennedyplatz 1
50569 Cologne
Germany
Phone: +49 (0)221 8885-3494
Fax: +49 (0)221 8885-4944
E-mail: [email protected]
Internet: www.lanxess.com
ISIN: DE0005470405
WKN: 547040
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 853031

 
End of Announcement DGAP News Service

853031  06-Aug-2019 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=853031&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 6.530,00 7.197,00 6.802,00 6.104,00 7.557,00 8.088,00 6.714,00
EBITDA1,2 709,00 935,00 910,00 757,00 863,00 826,00 328,00
EBITDA-Marge3 10,86 12,99 13,38 12,40 11,42 10,21
EBIT1,4 299,00 504,00 407,00 253,00 350,00 280,00 -668,00
EBIT-Marge5 4,58 7,00 5,98 4,14 4,63 3,46 -9,95
Jahresüberschuss1 124,00 523,00 191,00 902,00 267,00 251,00 444,00
Netto-Marge6 1,90 7,27 2,81 14,78 3,53 3,10 6,61
Cashflow1,7 868,00 586,00 643,00 585,00 407,00 159,00 838,00
Ergebnis je Aktie8 0,95 4,71 2,32 10,22 3,09 2,90 5,13
Dividende8 0,80 0,90 0,95 1,00 1,05 1,05 0,70
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Lanxess
WKN Kurs in € Einschätzung Börsenwert in Mio. €
547040 25,850 Halten 2.232,05
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
11,54 16,14 0,73 7,40
KBV KCV KUV EV/EBITDA
0,50 2,66 0,33 15,99
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
1,05 0,10 0,39 24.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 09.08.2024 07.11.2024 14.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
2,34% 0,49% -8,88% -28,37%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu LANXESS Aktiengesellschaft  ISIN: DE0005470405 können Sie bei EQS abrufen


Chemie , 547040 , LXS , XETR:LXS